Understanding the patient journey is vital to the development of new therapies and support programmes. Diagnosis is often delayed and it can be difficult to predict the course of a disease, particularly as patients are living longer as new therapies are introduced and supportive care improves.
The benefits of new treatments need to be measured against the costs and impact of existing care. Adequate data on burden of illness and real world evidence of benefit in the target population are needed to support market access.
We can design and implement a study to explore these issues and deliver the evidence you need.
What we can Provide
We are well equipped to design and carry out your real world evidence study through our:
Extensive experience and understanding of rare disorders.
Established and trusted relationships with patients.
Collaboration with patient groups around the world.